Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Whole Body Diffusion Weighted MRI (WB DWI) for the Management of Multiple Myeloma: High Concordance between MRI Diffuse Pattern and BONE Marrow Plasma CELL Infiltration RATE

Silvia Mangiacavalli, Zacchino Michela, MD, Virginia Valeria Ferretti, Claudio Salvatore Cartia, MD, Giovanni Savietto, MD, Pietro Benvenuti, MD, Marzia Varettoni, Sara Rattotti, Brociner Marco, Gabriele Merati, MD, Luca Arcaini

Blood (2019) 134 (Supplement_1): 5495.

https://doi.org/10.1182/blood-2019-126422

Published: 2019

Journal Articles

Real Life Use of Imaging in the Management of Newly Diagnosed Patients with Myeloma- Practical Perspectives from a UK Hospital

Ke Xu, MD, Lucy Fowkes, Fenella Willis, Yasmin Reyal

Blood (2019) 134 (Supplement_1): 5513.

https://doi.org/10.1182/blood-2019-121504

Published: 2019

Journal Articles

Long-Lasting Remissions for Myeloma Patients on Daratumumab Therapy from the GEN501 and GEN503 Trials

Agoston Gyula Szabo, MD, Monique C Minnema, MD PhD, Hareth Nahi, MD PhD, Torben Plesner, MD DSc

Blood (2018) 132 (Supplement 1): 3308.

https://doi.org/10.1182/blood-2018-99-111095

Published: 2018

Journal Articles

Risk Factors Associated with Development of Extramedullary Disease in Multiple Myeloma

Blood (2018) 132 (Supplement 1): 5596.

https://doi.org/10.1182/blood-2018-99-114854

Published: 2018

Journal Articles

Development of New Scoring System for Whole Body Magnetic Resonance Imaging for Evaluation of Multiple Myeloma Lesions

Natalia Neparidze, MD, Veronica Meawad, MD, James Elliott Brown, MD

Blood (2017) 130 (Supplement 1): 1757.

https://doi.org/10.1182/blood.V130.Suppl_1.1757.1757

Published: 2017

Journal Articles

Imaging of Plasma Cell Dyscrasias with FDG-PET/MRI: A Single-Center Experience

Tyler J Fraum, MD, Ephraim Parent, MD PhD, Monica Shokeen, PhD, Keith Stockerl-Goldstein, Michelle Miller-Thomas, MD, Farrokh Dehdashti, MD, Ravi Vij, MD, Kathryn J Fowler, MD

Blood (2016) 128 (22): 5611.

https://doi.org/10.1182/blood.V128.22.5611.5611

Published: 2016

Journal Articles

Clinical Features, Diagnosis, and Prognosis of 14 Cases of Neurolymphomatosis: Single Institutional Experience over 10 Years

Yoshiaki Abe, MD, Yoshiaki Usui, MD, Kentaro Narita, MD, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2016) 128 (22): 3042.

https://doi.org/10.1182/blood.V128.22.3042.3042

Published: 2016

Journal Articles

Validation of the Novel Criteria for the Definition of Symptomatic Myeloma: A Single Center Experience in 216 Patients with the Previous Diagnosis of Asymptomatic Disease

Efstathios Kastritis, MD, Evangelos Terpos, Maria Roussou, Vassilis Koutoulidis, Stavroula Giannouli, Maria Gavriatopoulou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Despoina Fotiou, Dimitrios Ziogas, Ioannis Panagiotidis, Despoina Kalapanida, Eirini Katodritou, Kostas Konstantopoulos, Lia A. Moulopoulos, Meletios A. Dimopoulos

Blood (2015) 126 (23): 4251.

https://doi.org/10.1182/blood.V126.23.4251.4251

Published: 2015

Journal Articles

WB-DWI MRI Scanning Outperforms FDG PET-CT for the Assessment of Myeloma Disease Burden

Charlotte Pawlyn, MB BChir, Martin F Kaiser, MD, Lucy Fowkes, MD, John R Jones, MD, Faith E Davies, MD, Gareth J Morgan, MD PhD, David Collins, BA, MInstP, Bhupinder Sharma, MD, Angela Riddell, MD, Christina Messiou, MD

Blood (2015) 126 (23): 1758.

https://doi.org/10.1182/blood.V126.23.1758.1758

Published: 2015

Journal Articles

Whole Body (WB) MRI in Newly Diagnosed Multiple Myeloma (MM): Fat Fraction Changes at 8 Weeks Predict Response to Induction with Bortezomib Regimens

Arash Latifoltojar, MB BS, MSc, MPhil, Kwee L Yong, MBChB, PhD, Margaret Hall-Craggs, BA, MB BS, MD, Neil Rabin, MB,BS, PhD, Rakesh Popat, MBBS, PhD, Alan Bainbridge, Magdalena Sokolska, Nikolaos Dikaios, Shirley D'Sa, MD FRCP, FRCPath, Ali Rismani, MBBS, Shonit Punwani, Mb BS, BSc, PhD

Blood (2015) 126 (23): 1850.

https://doi.org/10.1182/blood.V126.23.1850.1850

Published: 2015

Journal Articles

Prediction of Progression of Smouldering into Therapy Requiring Multiple Myeloma By Easily Accessible Clinical Factors [in 527 Patients]

Blood (2014) 124 (21): 2071.

https://doi.org/10.1182/blood.V124.21.2071.2071

Published: 2014

Journal Articles

Over 30% of Smoldering Myeloma Patients Have Tumor Cell Bone Marrow Infiltration Patterns Similar to Multiple Myeloma: A Large (n=544) Clinical Study Using Whole-Body MRI.

Jens Hillengass, MD, Kerstin Kilk, MD, Karin Listl, Thomas Hielscher, Kai Neben, MD, Dirk Hose, MD, PhD, Marc-André Weber, MD, Anthony D. Ho, MD, Hartmut Goldschmidt, MD, Ola Landgren, M.D., Ph.D.

Blood (2012) 120 (21): 2911.

https://doi.org/10.1182/blood.V120.21.2911.2911

Published: 2012

Journal Articles

Appearance of Monoclonal Plasma Cell Diseases in Whole Body MRI in 544 Patients and Correlation with Parameters of Disease Activity

Jens Hillengass, MD, Kerstin Kilk, MD, Karin Listl, Thomas Hielscher, Kai Neben, MD, Dirk Hose, MD, PhD, Anthony D. Ho, MD, Marc-André Weber, MD, Ola Landgren, M.D., Ph.D., Hartmut Goldschmidt, MD

Blood (2012) 120 (21): 4966.

https://doi.org/10.1182/blood.V120.21.4966.4966

Published: 2012

Journal Articles

The EOS ® System for the Detection of Bone Lesions in Patients with Multiple Myeloma,

Bastien Dutouquet, MD, Xavier Leleu, MD, PhD, Antoine Moraux, MD, Eileen Boyle, MD, Jordan Gauthier, MD, Houria Debarri, MD, Salomon Manier, MD, Marie Pierre Noel, MD, Thierry Facon, MD, Marie Helene Vieillard, MD, PhD, Anne Cotten, MD, Nathalie Boutry, MD, PhD

Blood (2011) 118 (21): 3921.

https://doi.org/10.1182/blood.V118.21.3921.3921

Published: 2011

Journal Articles

The Role of Digital Tomosynthesis In the Staging of Newly Diagnosed Multiple Myeloma: Preliminary Data

Nishant de Quadros, M.D., Javier Munoz, M.D., Marnix Van Holsbeeck, M.D., Joseph Craig, MD, Vrushali S. Dabak, MD, Mishal Lala, M.D., Philip Kuriakose, MD

Blood (2010) 116 (21): 4057.

https://doi.org/10.1182/blood.V116.21.4057.4057

Published: 2010

Journal Articles

Cytogenetic Abnormalities and Appearance of Multiple Myeloma in Whole Body-MRI.

Jens Hillengass, Kerstin Fechtner, Anna Jauch, Tobias Baeuerle, Thomas Hielscher, Christiane Heiss, Sofia Ayyaz, Dirk Hose, Marc-André Weber, Hartmut Goldschmidt, Kai Neben

Blood (2009) 114 (22): 4868.

https://doi.org/10.1182/blood.V114.22.4868.4868

Published: 2009

Journal Articles

Interest of Diffusion Weighted Magnetic Resonance Imaging for the Evaluation of Bone Marrow Infiltration in Multiple Myeloma, Smoldering Myeloma and Monoclonal Gammopathy of Undetermined Significance.

Olivier Decaux, Thierry Josseaume, Eric Brillet, Thierry Lamy, Marc Bernard, Martine Escoffre, Martine Sebillot, Bernard Grosbois, Regis Duvauferrier

Blood (2009) 114 (22): 4874.

https://doi.org/10.1182/blood.V114.22.4874.4874

Published: 2009

Journal Articles

The Role of Whole-Body Magnetic Resonance Imaging in the Staging and Follow-Up of Bone Disease in Multiple Myeloma.

M. Varettoni, MD, F. Calliada, MD, P. Zappasodi, MD, P. Arcuti, MD, S. Mangiacavalli, MD, C. Rusconi, MD, G. M. Pica, MD, M. Lazzarino, MD, A. Corso, MD

Blood (2005) 106 (11): 5063.

https://doi.org/10.1182/blood.V106.11.5063.5063

Published: 2005

Journal Articles

Whole Body MRI Versus Skeletal Survey in Multple Myeloma.

Johnny McHugh, Ciaran Johnston, Deirdre Duke, Patrick Thornton, Steve Eustace, Peter O’Gorman

Blood (2005) 106 (11): 5106.

https://doi.org/10.1182/blood.V106.11.5106.5106

Published: 2005

NARROW

Whole Body Diffusion Weighted MRI (WB DWI) for the Management of Multiple Myeloma: High Concordance between MRI Diffuse Pattern and BONE Marrow Plasma CELL Infiltration RATE

Real Life Use of Imaging in the Management of Newly Diagnosed Patients with Myeloma- Practical Perspectives from a UK Hospital

Long-Lasting Remissions for Myeloma Patients on Daratumumab Therapy from the GEN501 and GEN503 Trials

Risk Factors Associated with Development of Extramedullary Disease in Multiple Myeloma

Development of New Scoring System for Whole Body Magnetic Resonance Imaging for Evaluation of Multiple Myeloma Lesions

Imaging of Plasma Cell Dyscrasias with FDG-PET/MRI: A Single-Center Experience

Clinical Features, Diagnosis, and Prognosis of 14 Cases of Neurolymphomatosis: Single Institutional Experience over 10 Years

Validation of the Novel Criteria for the Definition of Symptomatic Myeloma: A Single Center Experience in 216 Patients with the Previous Diagnosis of Asymptomatic Disease

WB-DWI MRI Scanning Outperforms FDG PET-CT for the Assessment of Myeloma Disease Burden

Whole Body (WB) MRI in Newly Diagnosed Multiple Myeloma (MM): Fat Fraction Changes at 8 Weeks Predict Response to Induction with Bortezomib Regimens

Prediction of Progression of Smouldering into Therapy Requiring Multiple Myeloma By Easily Accessible Clinical Factors [in 527 Patients]

Over 30% of Smoldering Myeloma Patients Have Tumor Cell Bone Marrow Infiltration Patterns Similar to Multiple Myeloma: A Large (n=544) Clinical Study Using Whole-Body MRI.

Appearance of Monoclonal Plasma Cell Diseases in Whole Body MRI in 544 Patients and Correlation with Parameters of Disease Activity

The EOS ® System for the Detection of Bone Lesions in Patients with Multiple Myeloma,

The Role of Digital Tomosynthesis In the Staging of Newly Diagnosed Multiple Myeloma: Preliminary Data

Cytogenetic Abnormalities and Appearance of Multiple Myeloma in Whole Body-MRI.

Interest of Diffusion Weighted Magnetic Resonance Imaging for the Evaluation of Bone Marrow Infiltration in Multiple Myeloma, Smoldering Myeloma and Monoclonal Gammopathy of Undetermined Significance.

The Role of Whole-Body Magnetic Resonance Imaging in the Staging and Follow-Up of Bone Disease in Multiple Myeloma.

Whole Body MRI Versus Skeletal Survey in Multple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only